Providence Regional Cancer Partnership

The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy

Ekapun Karoopongse, Cecilia C.S. Yeung, John Byon et al. · PLoS ONE · 2014 · 32 citations · Full text

Histone Modifications, Epigenetic Change, Mixed-phenotype Acute Leukemia +19

Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy

Karen Kelly, Christopher G. Azzoli, Petr Zatloukal et al. · Journal of Thoracic Oncology · 2012 · 29 citations

Phase 2B, Prior Platinum-based Therapy, Medicine +8

Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors

Guy T. Clifton, Kaitlin M. Peace, Jarrod P. Holmes et al. · Clinical Immunology · 2019 · 23 citations

Breast Oncology, Oncology, Breast Cancer Patients +9

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Saul E. Rivkin, James Moon, Desiree Iriarte et al. · International Journal of Gynecological Cancer · 2019 · 16 citations

Identification of the Collagen Types Essential for Mammalian Breast Acinar Structures

Chandler R. Keller, Kelsey F. Ruud, Steve R. Martinez et al. · Gels · 2022 · 15 citations · Full text

Tissue Engineering, Engineering, Biomedical Engineering +16